Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Large Increase in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 7,700 shares, an increase of 234.8% from the February 28th total of 2,300 shares. Based on an average daily volume of 38,800 shares, the days-to-cover ratio is presently 0.2 days.

Reviva Pharmaceuticals Stock Up 4.7 %

NASDAQ:RVPHW opened at $0.05 on Friday. The company has a 50-day moving average of $0.12 and a 200-day moving average of $0.16. Reviva Pharmaceuticals has a 52 week low of $0.04 and a 52 week high of $0.78.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.